Letter from Chief Executive Officer, Catharine Smith

Dec 4, 2025

Dear Friends of the Termeer Institute,

The Termeer Institute is leading the way into a new era in life sciences—one where values-driven leaders are supported, empowered,and connected; scientific discovery knows no borders; and the exchange of ideas and experiences drives better health outcomes, all with the goal that every patient has a cure.

Board members, mentors, advisors, and funders like you provide the intellectual capital and resources necessary to fuel this change. We value our shared belief that bold leaders can change the course of human health. Here at the Termeer Institute we’ve seen the efficacy of our work with brilliant life science leaders and its transformational impact. What started as a tribute has become an internationally recognized organization, thanks to hundreds of the most talented leaders in the life sciences. As our global footprint expands, we honor Henri Termeer’s enduring principles of patient focus, humility, and relentless innovation, positioning us as a trusted convener in the biotech community.

That’s why, in 2025, we, as a team alongside our dedicated board, made the intentional decision to embark on several changes. Our new name, the Termeer Institute, reflects the life science industry’s view of our work and its application going forward. The name honors Henri’s legacy and signals our future – an institute built to cultivate leaders, connect communities, and accelerate patientcentered innovation worldwide.

2025 also marks a new chapter in our leadership-  one grounded in purpose and shaped by people who believe deeply in that mission. Geoff McDonough joined us this year as the organization’s first formal board chair, enthusiastically prepared to guide us into this next phase. To learn more about what the Institute has accomplished in 2025, check out our 2025 Impact Report.

Thank you for being an integral part of the Institute’s network of over 600 advocates committed to influence patient outcomes. With your continued partnership, our work as a catalyst for change in the life sciences will continue to prosper.

In gratitude,

Catharine Smith

Chief Executive Officer